AG0031Q7

3094-09-5 | Uridine, 5'-deoxy-5-fluoro-

Chemical structure of Uridine, 5'-deoxy-5-fluoro-, CAS 3094-09-5
AG0031Q7
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 3094-09-5
Catalog Number AG0031Q7(AGN-PC-0O8SGV)
Chemical Name Uridine, 5'-deoxy-5-fluoro-
EC Number 221-440-1
IUPAC Name 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoropyrimidine-2,4-dione
InChI InChI=1S/C9H11FN2O5/c1-3-5(13)6(14)8(17-3)12-2-4(10)7(15)11-9(12)16/h2-3,5-6,8,13-14H,1H3,(H,11,15,16)/t3-,5-,6-,8-/m1/s1
InChI Key ZWAOHEXOSAUJHY-ZIYNGMLESA-N
MDL Number MFCD00866530
Molecular Formula C9H11FN2O5
Molecular Weight 246.1924
SMILES C[C@@H]1[C@H]([C@H]([C@H](N2C(NC(C(F)=C2)=O)=O)O1)O)O
UNII V1JK16Y2JP
Synonyms
5'-deoxy-5'-fluorouridine, 5'-deoxy-5-fluorouridine, 5'-DFUR, 5'-fluoro-5'-deoxyuridine, doxifluridine, doxyfluridine, Furtulon, Ro 21-9738, doxifluridine, 5'-Deoxy-5-fluorouridine, 5-fluoro-5'-deoxyuridine, Furtulon, 3094-09-5, 5'-Dfur, Uridine, 5'-deoxy-5-fluoro-, Flutron, Doxifluridina, Doxifluridinum, 5'-Doxifluridine, Uridine-5'-deoxy-5-fluoro-, 5'dFUrd, Ro 21-9738, Doxifluridine [INN:JAN], UNII-V1JK16Y2JP, Ro 219738, Doxifluridinum [INN-Latin], CHEMBL1130, V1JK16Y2JP, Doxifluridina [INN-Spanish], CHEBI:31521, 1-(beta-D-5-Desoxyribofuranoxyl)-5-fluoruracil, EINECS 221-440-1, NCGC00093926-03, Doxifluridine (5-Fluoro-5'-deoxyuridine), DSSTox_CID_2967, 5'FDUR, DSSTox_RID_76809, DSSTox_GSID_22967, 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione, doxyfluridine, 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoropyrimidine-2,4-dione, 5'-dFUrd, Furtulon (TN), 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl]-5-fluoro-pyrimidine-2,4-dione, SMR000326811, CAS-3094-09-5, SR-01000075886, 5-DFUR, 5'-fluoro-5'-deoxyuridine, MFCD00866530, 38817-29-7, AK163078, (+)-Doxifluridine, PubChem21074, AC1L2BUF, 5-Deoxy-5-fluorouridine, 5-Fluoro-5;-deoxyuridine, AC1Q29PS, SCHEMBL8094, Doxifluridine (JP17/INN), Lopac0_000537, KSC492G6N, MLS001332579, MLS001332580, MLS002172440, MLS002207077, URI004, DTXSID2022967, CTK3J2366, KS-00000EUP, ZWAOHEXOSAUJHY-ZIYNGMLESA-N, HMS2090C22, HMS2231I05, HMS3261L15, ACN-S003358, AMC 0101, HY-B0021, ZINC1319177, ZX-AP001976, Tox21_111231, Tox21_500537, ANW-13803, BDBM50132295, CD-197, PC5775, s2045, AKOS015852921, AKOS015896821, Tox21_111231_1, API0015889, CCG-204627, CS-1270, DB12947, Doxifluridine/5-Fluoro-5'-deoxyuridine, KS-5065, LP00537, NCGC00093926-01, NCGC00093926-02, NCGC00093926-05, NCGC00261222-01, Ro-21-9738, CJ-04859, SRI-11552-08, SRI-11552_09, ZB016270, 5''-Deoxy-5-Fluorouridine (5''-Dfur), LS-160821, EU-0100537, C12739, D01309, F 8791, W-5145, 15185-EP2272827A1, 15185-EP2275420A1, 15185-EP2295055A2, 15185-EP2295416A2, 15185-EP2295426A1, 15185-EP2295427A1, 15185-EP2298748A2, 15185-EP2298764A1, 15185-EP2298765A1, 15185-EP2298768A1, 15185-EP2298778A1, 15185-EP2305642A2, 15185-EP2311453A1, 15185-EP2311808A1, 15185-EP2311829A1, 15185-EP2316832A1, 15185-EP2316833A1, 094F095, A820661, SR-01000075886-1, SR-01000075886-5, (+)-1-(beta-D-5'-Deoxyribofuranosyl)-5-fluorouracil, 5'-DFUR (5'-Deoxy-5-fluorouridine, Doxifluridine), BRD-K58262659-001-09-7, Capecitabine impurity B, European Pharmacopoeia (EP) Reference Standard, 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-2-oxolanyl]-5-fluoropyrimidine-2,4-dione, 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-3H-pyrimidine-2,4-dione, 5-fluoranyl-1-[(2R,3R,4S,5R)-5-methyl-3,4-bis(oxidanyl)oxolan-2-yl]pyrimidine-2,4-dione, Capecitabine Related Compound B, United States Pharmacopeia (USP) Reference Standard, 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl)-5-fluoropyrimidine-2,4(1H,3H)-dione, 1-((2R,5R)-3,4-Dihydroxy-5-methyl-tetrahydro-furan-2-yl)-5-fluoro-1H-pyrimidine-2,4-dione, 1-((4S,2R,3R,5R)-3,4-Dihydroxy-5-methyloxolan-2-yl)-5-fluoro-1,3-dihydropyrimidine-2,4-dione, 1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoropyrimidine-2,4(1H,3H)-dione (5'-Deoxy-5-fluorouridine), 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione, 5-Fluorodeoxyuridine, 5'-DEOXYFLUOROURIDINE, D03KXY, 5'-deoxy-5'-fluorouridine, C9H11FN2O5, CID18343, CS-O-07516, 5-Fluoro-5'-deoxyuridine (doxifluridine), 5'-Deoxy-5-fluorouridine, 98% - 1G 1g, C025034,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited